{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:45:35Z","timestamp":1778651135482,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.ajo.2015.04.040","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T16:43:52Z","timestamp":1430585032000},"page":"220-227.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome"],"prefix":"10.1016","volume":"160","author":[{"given":"Omar K.","family":"Ozgur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8050-3588","authenticated-orcid":false,"given":"Vivian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrill","family":"Kies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William N.","family":"William","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Migden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley A.","family":"Thuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Esmaeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2015.04.040_bib1","first-page":"197","article-title":"Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma","volume":"5","author":"Macha","year":"2013","journal-title":"Cancer Manag Res"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.040_bib2","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0161-6420(99)90161-6","article-title":"Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota","volume":"106","author":"Cook","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2015.04.040_bib3","series-title":"Ophthalmic Oncology","first-page":"113","article-title":"Management of primary eyelid cancers","author":"Savar","year":"2011"},{"issue":"10","key":"10.1016\/j.ajo.2015.04.040_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archderm.135.10.1177","article-title":"A systematic review of treatment modalities for primary basal cell carcinomas","volume":"135","author":"Thissen","year":"1999","journal-title":"Arch Dermatol"},{"issue":"23","key":"10.1016\/j.ajo.2015.04.040_bib5","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1113538","article-title":"Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome","volume":"366","author":"Tang","year":"2012","journal-title":"N Engl J Med"},{"issue":"4 Suppl","key":"10.1016\/j.ajo.2015.04.040_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.sder.2011.11.002","article-title":"Emerging treatments and signaling pathway inhibitors","volume":"30","author":"Tang","year":"2011","journal-title":"Semin Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.ajo.2015.04.040_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.12998\/wjcc.v2.i9.432","article-title":"Targeting EGFR and sonic hedgehog pathways for locally advanced eyelid and periocular carcinomas","volume":"2","author":"Yin","year":"2014","journal-title":"World J Clin Cases"},{"issue":"7","key":"10.1016\/j.ajo.2015.04.040_bib8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/jamaophthalmol.2014.1787","article-title":"Indications and limitations of vismodegib for basal cell carcinoma","volume":"132","author":"Yin","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2015.04.040_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/IOP.0b013e3182831bf3","article-title":"Targeted therapy for orbital and periocular basal cell carcinoma and squamous cell carcinoma","volume":"29","author":"Yin","year":"2013","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"6605","key":"10.1016\/j.ajo.2015.04.040_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/384176a0","article-title":"Biochemical evidence that patched is the Hedgehog receptor","volume":"384","author":"Marigo","year":"1996","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.ajo.2015.04.040_bib11","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1158\/0008-5472.CAN-14-1666","article-title":"Sonic hedgehog signaling in basal cell nevus syndrome","volume":"74","author":"Athar","year":"2014","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.ajo.2015.04.040_bib12","first-page":"4562","article-title":"Mutations in the human homologue of Drosophila patched (PTCH) in basal cell carcinomas and the Gorlin syndrome: different in\u00a0vivo mechanisms of PTCH inactivation","volume":"56","author":"Unden","year":"1996","journal-title":"Cancer Res"},{"issue":"6653","key":"10.1016\/j.ajo.2015.04.040_bib13","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/39918","article-title":"Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours","volume":"389","author":"Dahmane","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ajo.2015.04.040_bib14","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/1097-0142(197912)44:6<2294::AID-CNCR2820440644>3.0.CO;2-G","article-title":"The basal cell nevus syndrome: disasters occurring among a series of 36 patients","volume":"44","author":"Southwick","year":"1979","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ajo.2015.04.040_bib15","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-10-2745","article-title":"Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors","volume":"17","author":"LoRusso","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.ajo.2015.04.040_bib16","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1016\/j.bmcl.2009.08.049","article-title":"GDC-0449-a potent inhibitor of the hedgehog pathway","volume":"19","author":"Robarge","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.ajo.2015.04.040_bib17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jamaophthalmol.2013.5018","article-title":"Vismodegib for periocular and orbital basal cell carcinoma","volume":"131","author":"Gill","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.040_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1524-4725.2012.02367.x","article-title":"Periocular cutaneous malignancies: a review of the literature","volume":"38","author":"Slutsky","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ajo.2015.04.040_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/IOP.0000000000000388","article-title":"Efficacy of vismodegib (Erivedge) for basal cell carcinoma involving the orbit and periocular area","author":"Demirci","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"10","key":"10.1016\/j.ajo.2015.04.040_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1001\/jamaophthalmol.2013.4430","article-title":"Vismodegib as eye-sparing adjuvant treatment for orbital basal cell carcinoma","volume":"131","author":"Kahana","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2015.04.040_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.5858\/133.8.1256","article-title":"Introduction of the 7th edition eyelid carcinoma classification system from the American Joint Committee on Cancer-International Union Against Cancer staging manual","volume":"133","author":"Ainbinder","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajo.2015.04.040_bib22","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. NIH Publication No. 09\u20135410. Published May 28, 2009. Available at http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed February 1, 2015."},{"issue":"2","key":"10.1016\/j.ajo.2015.04.040_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.ajo.2015.04.040_bib24","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1113713","article-title":"Efficacy and safety of vismodegib in advanced basal-cell carcinoma","volume":"366","author":"Sekulic","year":"2012","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ajo.2015.04.040_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","article-title":"Inhibition of the hedgehog pathway in advanced basal-cell carcinoma","volume":"361","author":"Von Hoff","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajo.2015.04.040_bib26","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaad.2014.05.020","article-title":"An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma","volume":"71","author":"Ally","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.ajo.2015.04.040_bib27","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/archdermatol.2012.2354","article-title":"Initial assessment of tumor regrowth after vismodegib in advanced basal cell carcinoma","volume":"148","author":"Chang","year":"2012","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.ajo.2015.04.040_bib28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/PRS.0b013e3181ea450d","article-title":"What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature","volume":"126","author":"Gulleth","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajo.2015.04.040_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/eye.2012.230","article-title":"5 years review of periocular basal cell carcinoma and proposed follow-up protocol","volume":"27","author":"Ho","year":"2013","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2015.04.040_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IOP.0b013e3182a74f21","article-title":"Eyelid margin basal cell carcinoma managed with full-thickness en-face frozen section histopathology","volume":"30","author":"Gill","year":"2014","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajo.2015.04.040_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.2004.06047.x","article-title":"Mohs' micrographic surgery for treatment of basal cell carcinoma of the face\u2013results of a retrospective study and review of the literature","volume":"151","author":"Smeets","year":"2004","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939415002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939415002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:13:51Z","timestamp":1757596431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939415002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0002939415002433"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2015.04.040","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2015.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}